Due to the lack of shared detection methods, the percentage of TAMs within MM patients’ BM has been reported to be highly variable (from near 0 up to 25%), increasing during evolution from MGUS to MM, with reports indicating a worse prognosis for patients with a high CD163+ and CD206+ TAM infiltration [40,41,42]. This evidence concerns the gene MRC1 and Miyoshi myopathy.